Independent, research-driven ESG assessments. We look beyond corporate marketing to analyze actual emissions, biodiversity investments, and ethical track records.
AstraZeneca demonstrates leading environmental policies in its direct operations, but carbon emissions and resource footprints remain heavily exposed in its global supply chain.
First Solar pairs validated climate targets with industry-leading module recycling, though rapid factory expansion has increased its near-term operational emissions.
Microsoft remains highly transparent and renewable-heavy, but AI data centre growth has pushed Scope 3 emissions and water demand into sharper focus.
NextEra is a major clean-energy developer with an ambitious Real Zero target, but fossil generation, lobbying concerns, and Scope 1 emissions keep it under scrutiny.
Orsted remains a benchmark renewable transition story, with deep emissions reductions, offshore wind leadership, and increasingly explicit biodiversity commitments.
SSE plc is a leading UK clean-energy champion, expanding wind and grid infrastructure with strong decarbonisation commitments, though legacy gas assets remain a transition risk.
Tomra is a circular-economy enabler with validated climate targets, but its sold-product electricity use makes Scope 3 the key metric to watch.
Unilever is an industry benchmark in deforestation-free sourcing and agricultural sustainability, though progress on reducing post-consumer plastic packaging remains slow.
Vestas is core infrastructure for the wind transition, but turbine blade circularity and project-level biodiversity impacts remain important watchpoints.